Mahmut Gumus

Statistics

Publications

Citations

H-Index

Active since

2025

Affiliations

Istanbul Medeniyet University(Current)

Dnipro State Medical University

Mahmut Gumus is an author at Istanbul Medeniyet University specializing in programmed cell death ligand 1 inhibition, thoracic oncology, and chemotherapy.

ORCID

Publications per year

2025–2025

Publications

Abstract CT051: SKYSCRAPER-01: A phase III, randomized trial of tiragolumab (tira) + atezolizumab (atezo) versus placebo (pbo) + atezo in patients (pts) with previously-untreated PD-L1-high, locally advanced unresectable/metastatic NSCLC

Solange Peters, Roy S. Herbst, Hidehito Horinouchi et al. · Cancer Research · 2025 · 20 citations

Medicine, Oncology, Pharmacology +12

Cemiplimab Monotherapy for First-Line Treatment of Patients with Advanced NSCLC With PD-L1 Expression of 50% or Higher: Five-Year Outcomes of EMPOWER-Lung 1

Ana Baramidze, Ahmet Sezer, Mustafa Özgüroğlu et al. · Journal of Thoracic Oncology · 2025 · 16 citations · Full text

Medicine, Oncology, Pharmacology +17

1–2 of 2